Listed in India, the valuation of Aster DM Healthcare stands at USD $ 1.4 billion as on date
The promoters of Aster DM Healthcare have increased their shareholding in the India listed company by 4 per cent from 37.88 per cent to 41.88 per cent, after acquiring additional stake from one of the large private equity investors at an additional investment of Rs 460 Crore (Dh. 207 million).
Speaking on the increase in stake, Dr Azad Moopen, Founder Chairman and Managing Director, Aster DM Healthcare said, “The increase of our stake in Aster DM Healthcare is a reiteration of our confidence in the business across geographies and our commitment to the patients and employees who have placed their trust in us. As a family we are fully committed to Aster and promise our continued involvement in GCC and India businesses both in terms of ownership and management.”
“Aster DM Healthcare, with a turnover of Rs. 10,253 crore or AED 5 billion in FY 2021-22, is performing very well during this FY in turnover and profits with an exciting stage of growth, due to restructuring of India and GCC businesses being pursued actively. In India we are moving ahead with new projects like 350-bedded Aster Capital Hospital in Trivandrum – Kerala, 200 bedded Aster MIMS Hospital in Kasargod – Kerala, 150-bedded Aster Narayanadri Hospital in Tirupati – Andhra Pradesh, 100-bedded Aster G Madegowda Hospital in Mandya – Karnataka among others. We have also rolled out 239 Aster pharmacies and 177 Aster Labs & patient experience centres already. With 4,095 beds in 15 hospitals in India going up to 4,670 in 18 hospitals next financial year, Aster shall be connecting all the above through the myAster App that is going to be launched this year to give omni channel care to our customers”, he added.